• Workflow Targets Anticoagulation Errors After Epidural Placement

    Workflow Targets Anticoagulation Errors  After Epidural Placement
    By Michael VlessidesA standardized, multidisciplinary workflow eliminated inadvertent administration of low-molecular-weight heparin (LMWH) after epidural placement at a Canadian tertiary care center, according to a quality improvement study presented at the 2026 spring meeting of the American Society of Regional Anesthesia and Pain Medicine, in Phoenix (abstract 2299554).The initiative treated inappropriate anticoagulant administration as a preventable system failure rather than an individual c
  • PACU Medication Overrides Plummet After ADC Optimization

    PACU Medication Overrides Plummet After ADC Optimization
    By Karen BlumClare Livingston, PharmDA hospital PACU has a high patient turnover rate, high clinical acuity, and fast pace of care, said Clare Livingston, PharmD, an informatics system pharmacist specialist with Inova Health System, a five-hospital system in Northern Virginia. So, when Dr. Livingston and her colleagues noted that medication errors in the PACU at one of their hospitals were often tied to nurses overriding orders from automated dispensing cabinets (ADCs), they decided to take acti
  • How the Babytam Trial Is Shaping the Conversation Around Preventive Oncology

    How the Babytam Trial Is Shaping the Conversation Around Preventive Oncology
    Originally published by our sister publication Clinical Oncology NewsBy Amy KraftCHICAGO—A pooled analysis of low-dose tamoxifen, or “Babytam,” in women with noninvasive breast neoplasia found that the regimen significantly reduced breast cancer events and that menopausal status modified the benefit. Ipsilateral risk reduction predominated in postmenopausal women, whereas prevention of contralateral breast cancer was confined to premenopausal women.The findings, presented at the ASCO 2026
  • IV Iron Boosts Quality of Life in IBD, Plus New Data on Hepcidin’s Predictive Value

    IV Iron Boosts Quality of Life in IBD, Plus New Data on Hepcidin’s Predictive Value
    figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }Anna Kovalchuk – stock.adobe.comBy Gina ShawA single high-dose infusion of IV iron improved quality of life within about six weeks in patients with
  • Advertisement

  • Iron Studies Ordered in Fewer Than 1 in 4 Heart Failure Admissions

    Iron Studies Ordered in Fewer Than 1 in 4 Heart Failure Admissions
    By Gina ShawIron studies were available for fewer than 1 in 4 patients admitted with acute decompensated heart failure at a regional hospital, according to a retrospective study of 2,275 admissions (J Cardiovasc Transl Res 2026;19:54).The characteristics that predicted testing—anemia, low mean corpuscular volume (MCV), and stage 3 chronic kidney disease (CKD)—suggest that clinicians were working up anemia rather than iron deficiency in heart failure, the investigators concluded.The 2022 Aner
  • Anemia Before TAVI Tied to Higher Death, HF Hospitalization Risk

    Anemia Before TAVI Tied to Higher Death, HF Hospitalization Risk
    By Gina ShawPatients who come to transcatheter aortic valve replacement (TAVR) with anemia and then have a significant drop in hemoglobin around the procedure face more than twice the risk for death and heart failure hospitalization over three years compared with patients with neither condition, according to a Cleveland Clinic study.“Both baseline anemia and significant periprocedural hemoglobin decline independently and additively confer increased risk of three-year mortality, while the incre
  • Lessons for Compounders From USP <795>, <797>, and <800> Inspections

    Lessons for Compounders From USP &lt;795&gt;, &lt;797&gt;, and &lt;800&gt; Inspections
    By Gina ShawJaclyn M. Jaskowiak, PharmDMore than two years after the revised USP compounding chapters became compendially applicable and enforceable in November 2023, compounders are learning more about what regulators look for and where pharmacies fall short. At the 2026 InformaConnect Compounding Pharmacy Compliance meeting, in Philadelphia, experts highlighted several common gaps in places that are easy to overlook, starting with the nonsterile chapter, USP <795>.“I think <795>
  • Neoadjuvant Chemoimmunotherapy for NSCLC Associated With Survival Benefit, Even in Older Patients

    Neoadjuvant Chemoimmunotherapy for NSCLC Associated With Survival Benefit, Even in Older Patients
    Originally published by our sister publication Clinical Oncology NewsBy Amy KraftNeoadjuvant chemoimmunotherapy is associated with significantly improved overall survival (OS) compared with adjuvant chemoimmunotherapy in patients with resectable stage II to III non–small cell lung cancer (NSCLC), according to a retrospective analysis presented at ASCO 2026.A second analysis found that pathologic complete response (pCR) rates with neoadjuvant chemoimmunotherapy in patients aged 75 years or olde
  • Advertisement

  • 3 Steps to Get IV Workflow Management Systems Right

    3 Steps to Get IV Workflow Management Systems Right
    By Jennifer Smith, PharmD, BCSCPIntravenous workflow management systems are becoming standard in hospital pharmacies. Adoption of sterile-preparation safety technology climbed from 36% of hospitals in 2018 to nearly two-thirds in 2024, according to an ASHP national practice survey.Barcode scanning, gravimetric and volumetric checks, standardized beyond-use dating (BUD), and remote verification add safety layers intended to catch errors before they reach a patient. But adoption alone doesn’t gu
  • Pharmacists Key to Helping Women Navigate Menopause Symptoms and Treatments

    Pharmacists Key to Helping Women Navigate Menopause Symptoms and Treatments
    Originally published by our sister publication Specialty Pharmacy Continuumfigure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }credit: Credit: AyaLinesDesign - stock.adobe.comBy Fran KritzThe importanc
  • FDA Approves Hibsago for Chronic HBV Infection

    FDA Approves Hibsago for Chronic HBV Infection
    Originally published by our sister publication Infectious Disease Special EditionBy Meaghan Lee CallaghanThe FDA has approved bepirovirsen (Hibsago, GSK) for the treatment of chronic hepatitis B virus (HBV) infection.The drug, a first-in-class antisense oligonucleotide, is approved for use in adult patients without cirrhosis who are receiving nucleoside/nucleotide analog reverse transcriptase inhibitor therapy, who have suppressed HBV DNA, and with HBV surface antigen (HBsAg) levels at or less t
  • Getting the Most Value Out of IV Software Products

    Getting the Most Value Out of IV Software Products
    By Karen BlumIn 2020, pharmacists with the Spaulding Rehabilitation Network purchased an IV solution software product to track training and activities modules related to IV sterile compounding. However, they soon discovered the program could be used for so much more outside the clean room.They launched the product initially in the clean room of their primary hospital, one of three hospitals and nursing homes in the Boston area that are part of Mass General Brigham. “The idea was to get rid of
  • New Cabotegravir Data at IDWeek 2026

    New Cabotegravir Data at IDWeek 2026
    By Meaghan Lee Callaghan and Landon GrayNew research on the real-world use of cabotegravir for pre-exposure prophylaxis (Apretude, ViiV Healthcare) and also data on cabotegravir/rilpivirine (Cabenuva, ViiV Healthcare) has been presented at IDWeek 2026, in Washington, D.C. The data, now spanning out to 5 years, shows good results for people who want to prevent HIV infection or want to keep their infections down to undetectable levels.ViiV’s CMO Jean Van Wyk, MBChB, MFPM, sat down with Infectio
  • Nutritional Challenges in Neurodegenerative Diseases

    Nutritional Challenges in Neurodegenerative Diseases
    By Gina ShawDespite being distinct diseases, amyotrophic lateral sclerosis (ALS), Parkinson’s, and dementia share a largely common set of nutritional challenges: self-feeding difficulty, gastrointestinal symptoms, dysphagia, medication interactions, feeding tube considerations, and energy expenditure abnormalities. Unfortunately, there is a lack of hard evidence that practitioners can turn to when managing the nutritional needs of patients with these complex neurodegenerative diseases, experts
  • Pemgarda Pre-Exposure Prophylaxis Appears Safe and Effective in Advanced HIV, Blood Cancers

    Pemgarda Pre-Exposure Prophylaxis Appears Safe and Effective in Advanced HIV, Blood Cancers
    Originally published by our sister publication Infectious Disease Special EditionBy Jenny Blair, MD, MS Michael Mina, MD, PhDTwo studies of the anti-SARS-CoV-2 monoclonal antibody pemivibart (Pemgarda, Invivyd) suggest it is safe and effective for pre-exposure prophylaxis (PrEP) among patients with advanced HIV or hematologic malignancies.“For individuals who can’t mount an immune response, this can be a life-saving drug,” said Michael Mina, MD, PhD, the chief medical officer and chief epi
  • Extending BCMA Into the OR Tests Workflow—and Culture

    Extending BCMA Into the OR Tests Workflow—and Culture
    By Gina ShawBringing barcode medication administration (BCMA) into ORs remains one of medication safety’s most persistent challenges, but one that is increasingly achievable with the right preparation, multidisciplinary buy-in, and workflow flexibility, according to presenters at the ASHP Midyear 2025 Clinical Meeting & Exhibition, in Las Vegas. The experiences of several health systems demonstrate how perioperative care teams are tackling the logistical barriers to close the gap in BCMA a
  • Preparing for America’s Next Top (Drug) Models

    Preparing for America’s Next Top (Drug) Models
    Originally published by our sister publication Specialty Pharmacy Continuumfigure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }Celt Studio, sherryvsmith - stock.adobe.comBy Gina ShawFederal drug pricin
  • More HPV Doses Are Associated With Lower Cervical Cancer Incidence

    More HPV Doses Are Associated With Lower Cervical Cancer Incidence
    Originally published by our sister publication Specialty Pharmacy ContinuumBy Marcus A. BanksTwo or three HPV vaccine doses are associated with a lower incidence of cervical cancer than one dose, according to a retrospective analysis from the West Virginia University (WVU) School of Pharmacy. The analysis earned a platinum abstract award at AMCP Nexus 2026, in San Diego.figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure
  • A String of Practice Pearls on AI, Better Labeling, and Naloxone

    A String of Practice Pearls on AI, Better Labeling, and Naloxone
    By Karen BlumThree pharmacy initiatives show how practical changes can strengthen medication safety and patient care: an in-house artificial intelligence model that helps identify medication errors in voluntary reports; redesigned labels that reduce reliance on auxiliary stickers; and an emergency department program that puts take-home naloxone kits within reach of patients at risk for overdose.1AI Models Can Help Review Med Safety EventsAn in-house developed AI model can help pharmacists and th
  • NASP Survey: Trust, Communication With Pharmacists Key Patient Satisfiers

    NASP Survey: Trust, Communication With Pharmacists Key Patient Satisfiers
    Originally published by our sister publication Specialty Pharmacy ContinuumBy Karen BlumCommunication with the specialty pharmacy team, trust and confidence in the pharmacists or nurses, and refill access and delivery timeliness are key drivers of patient satisfaction, according to the National Association of Specialty Pharmacy’s (NASP’s) 2025 Patient Satisfaction Survey.figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }f
  • Proactive Copay Savings Linked to Better Adherence in 2 Health Plan Studies

    Proactive Copay Savings Linked to Better Adherence in 2 Health Plan Studies
    Originally published by our sister publication Specialty Pharmacy Continuumfigure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }Credit ©McMahon GroupBy Gina ShawHealth plans that offer members point-of
  • Managed Care AI Is Outpacing Governance, Pharmacy Experts Warn

    Managed Care AI Is Outpacing Governance, Pharmacy Experts Warn
    Originally published by our sister publication Specialty Pharmacy Continuumfigure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }©McMahon GroupBy Gina ShawHealth plans and pharmacy benefit managers unde
  • Beyond the Error: Recognizing And Addressing Second Victim Syndrome

    Beyond the Error: Recognizing And Addressing Second Victim Syndrome
    Jennifer Phillips, PharmD, BCPSUIC Retzky College of PharmacyDrug Information GroupChicago, IllinoisBonnie Bachenheimer, PharmD, BCPSAdvocate Health Department of PharmacyDrug Policy CenterChicago, IllinoisThe term “second victim” was first coined by Albert Wu, MD, in a 2000 editorial, where he discussed the profound psychological impact that a medical error can have on practicing clinicians and the need for a culture and systems that support affected individuals.1A 2013 systematic review id
  • HealthBeacon Plans Pill Adherence Tool

    HealthBeacon Plans Pill Adherence Tool
    By Marcus A. BanksFrom reducing the guesswork around specialty drug coverage to identifying reg flags for oral and injectable medication noncompliance, a new generation of pharmacy technologies showcased at Asembia’s AXS26 Summit, in Las Vegas, promises practical solutions to some of specialty pharmacy’s most persistent challenges.This year, Irish health tech company HealthBeacon—a subsidiary of Hamilton Beach Health—plans to launch a device to improve medication adherence for pills. The
  • Manufacturer Claims Data Demands Put 340B Pricing at Risk as Rebate Pilot Nears

    Manufacturer Claims Data Demands Put 340B Pricing at Risk as Rebate Pilot Nears
    figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }©McMahon GroupBy Gina ShawDrug manufacturers have begun enforcing their 340B claims data policies, moving pharmacies with unvalidated purchases into
  • Highlights in HD Testing, Patient Monitoring, and Inventory Management

    Highlights in HD Testing, Patient Monitoring, and Inventory Management
    By Marcus A. BanksThe ASHP Midyear 2025 Clinical Meeting & Exhibition, in Las Vegas, featured technologies to improve hazardous drug sampling, enhance real-time response to patient emergencies, and provide more customized high-density storage.BD, ChemoGLO Streamline Hazardous Drug TestingBD and ChemoGLO now offer streamlined hazardous drug detection that only requires one wipe sample per location for all analyses, rather than having to use different collection kits and wiping side by side.Th
  • EDSA Pilot Elevates Supply Chain Transparency

    EDSA Pilot Elevates Supply Chain Transparency
    By Gina ShawApril GilesA first-of-its-kind supply chain transparency initiative has demonstrated that hospitals, distributors, and other stakeholders can share sensitive inventory data across organizational boundaries—and that doing so creates real planning value even when no drug shortage is underway.The Drug Resiliency & Transparency Pilot, led by the End Drug Shortages Alliance (EDSA), emerged from an August 2024 White House roundtable under the Cancer Moonshot initiative that focused o
  • IV Workflow Management Systems Keep Pace With Expanding Ambulatory Infusion Market

    IV Workflow Management Systems Keep Pace  With Expanding Ambulatory Infusion Market
    By Gina ShawIV workflow management systems (IVWMS) have long been a fixture of inpatient sterile compounding, and their footprint is expanding rapidly. Health systems are now pushing these platforms into ambulatory infusion centers, 503B outsourcing facilities, and home infusion pharmacies, each of which carries its own safety demands, regulatory requirements, and operational constraints.“This is encouraging,” said Mark Neuenschwander, the founding director of the THRIV Coalition for IV Accu
  • The Value Case for Outpatient ID Pharmacy

    By Gina ShawTodd Sorensen, PharmDWhen Todd Sorensen, PharmD, asked a room of infectious disease pharmacists at the newly combined Making a Difference in Infectious Diseases and Society of Infectious Disease Pharmacists 2026 meeting, in Orlando, Florida, how many were actively billing fee-for-service for their cognitive work, not a single hand went up. The same question in the previous session had yielded the same answer: none.Dr. Sorensen, the senior executive associate dean for strategic initia
  • ACHC Opens Simulated Cleanroom Suite for Hands-on Sterile Compounding Training

    ACHC Opens Simulated Cleanroom Suite for Hands-on Sterile Compounding Training
    By Gina ShawThe Accreditation Commission for Health Care (ACHC) has opened a fully functioning simulated cleanroom suite at its new headquarters in Cary, North Carolina, giving pharmacists and pharmacy technicians a place to practice and validate sterile compounding technique under USP General Chapter <797> and <800> conditions in a near-identical environment to a working pharmacy, without interrupting operations or creating any potential patient care issues.The facility, managed by

Follow @newsl_pharmacy on Twitter!